FDA issued a Warning Letter to Cambrex Profarmaco Milano Srl on 8/12/2009 as a result of this inspection.
483 Cambrex Profarmaco Milano Srl Mar 2009

483 Cambrex Profarmaco Milano Srl Mar 2009

$119 - Not in Stock

FDA investigators audited the Cambrex Profarmaco Milano Srl - Paullo, Italy facility and issued inspectional observations (via FDA 483) on 31 Mar 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Mar 2009
  • Location: Paullo, Italy
  • FEI: 3003723076

Pre-Order Not Available